S. Lago

发表

Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment.

B. Crespo-Facorro, S. Papiol, S. Bahn, 2019, JAMA psychiatry.

Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks

J. M. Ramsey, S. Baron-Cohen, V. Arolt, 2018, Molecular Psychiatry.

Functional patient-derived cellular models for neuropsychiatric drug discovery

S. Bahn, Santiago G. Lago, Jakub Tomasik, 2021, Translational Psychiatry.

Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood

J. Cooper, S. Bahn, S. Ozcan, 2020, Brain, Behavior, and Immunity.

Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients

P. Guest, S. Bahn, J. Steiner, 2016, Brain, Behavior, and Immunity.

Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum

J. M. Ramsey, S. Baron-Cohen, V. Arolt, 2020, Brain, Behavior, and Immunity.

Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo

J. M. Ramsey, S. Haggarty, B. Crespo-Facorro, 2019, Science Advances.

Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia

B. Crespo-Facorro, S. Papiol, S. Bahn, 2022, Brain, Behavior, and Immunity.

The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets

S. Bahn, Santiago G. Lago, S. Lago, 2022, NPJ genomic medicine.

The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets

S. Bahn, Santiago G. Lago, S. Lago, 2022, npj Genomic Medicine.

A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data

J. Cooper, S. Bahn, D. Mirea, 2021, Translational Psychiatry.

Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.

S. Bahn, Santiago G. Lago, S. Lago, 2018, ACS chemical neuroscience.

Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients

J. Cooper, K. Weigelt, H. Drexhage, 2018, Brain, Behavior, and Immunity.

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers

S. Baron-Cohen, V. Arolt, B. Crespo-Facorro, 2022, Translational Psychiatry.